Holen Sie sich die Stockscreener-App
28.08
1.65%
-0.47
Handel nachbörslich:
28.08
Schlusskurs vom Vortag:
$28.55
Offen:
$28.52
24-Stunden-Volumen:
223.12K
Relative Volume:
0.79
Marktkapitalisierung:
$1.24B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-10.91%
1M Leistung:
-26.49%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$27.00
$28.52
1-Wochen-Bereich:
$27.00
$33.18
52-Wochen-Spanne:
$24.15
$40.17
Avalyn Pharma Inc Stock (AVLN) Company Profile
Firmenname
Avalyn Pharma Inc
Sektor
Branche
Telefon
(206) 707-0340
Adresse
105 W FIRST ST., BOSTON
Compare AVLN vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVLN
Avalyn Pharma Inc
|
28.08 | 1.24B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Avalyn Pharma Inc Aktie (AVLN) Neueste Nachrichten
State Street Corp Makes New $10.50 Million Investment in Avalyn Pharma Inc. $AVLN - MarketBeat
Avalyn Pharma Inc. Stock Price Prediction: Today, Tomorrow, Next Week (AVLN) - Traders Union
Avalyn Pharma (NASDAQ:AVLN) Stock Price Down 9.2%Here's Why - MarketBeat
Avalyn Pharma (AVLN) Following AP02 Phase 1 Data Is Its Valuation Too Pricey - Yahoo Finance
Live Avalyn Pharma Inc. (AVLN) Technical Analysis - Traders Union
Avalyn Publishes Phase 1 Data Highlighting AP02’s Lung-Targeted Delivery and Encouraging Safety Profile - Stock Titan
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to S&P Global BMI Index - marketscreener.com
Avalyn Pharma (NASDAQ:AVLN) Cut to "Sell" at Wall Street Zen - MarketBeat
Avalyn Pharma (NASDAQ:AVLN) Shares Down 4.4%Here's What Happened - MarketBeat
Avalyn Pharma (NASDAQ: AVLN) Appoints Robert Meyer to Board with 31,182-Share Stock Option - Kalkine Media
Avalyn Pharma appoints former FDA official to board By Investing.com - Investing.com Canada
Avalyn Pharma appoints former FDA official to board - Investing.com
Avalyn Pharma (AVLN) adds ex-FDA leader to its board - Stock Titan
A former FDA leader with 25 years’ experience joins Avalyn’s board - Stock Titan
Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors - finance.yahoo.com
Avalyn Pharma (NASDAQ:AVLN) Shares Gap UpShould You Buy? - MarketBeat
Avalyn Pharma (NASDAQ:AVLN) Trading Up 6.8%Time to Buy? - MarketBeat
Avalyn Pharma (NASDAQ:AVLN) Rating Increased to Hold at Wall Street Zen - MarketBeat
Bank of New York Mellon Corp Acquires New Shares in Avalyn Pharma Inc. $AVLN - MarketBeat
Avalyn Pharma presents AP01 lung distribution modeling data By Investing.com - Investing.com Canada
Avalyn Pharma presents AP01 lung distribution modeling data - investing.com
People with lung scarring are willing to travel for trials, Avalyn survey finds - Stock Titan
Avalyn Pharma Inc. (NASDAQ:AVLN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Avalyn Pharma Inc. Common Stock (NASDAQ: AVLN) Stock Price, News & Analysis - Kalkine
AVLN Options Overview History for Avalyn Pharma Stock - Barchart.com
Braidwell LP Invests $26.38 Million in Avalyn Pharma Inc. $AVLN - MarketBeat
Montanova Capital LLC Takes Position in Avalyn Pharma Inc. $AVLN - MarketBeat
Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026 - Barchart.com
Avalyn will present a model of how an inhaled treatment may spread through the lungs - Stock Titan
AVLN Options Volatility — NASDAQ:AVLN - TradingView
AVLN Options Chain — NASDAQ:AVLN - TradingView
Avalyn Pharma (NASDAQ:AVLN) Sets New 1-Year HighHere's Why - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Avalyn Pharma (NASDAQ:AVLN) Cut to Sell at Wall Street Zen - MarketBeat
Novo Holdings A/S (AVLN) discloses 8.8% beneficial stake in Avalyn Pharma - Stock Titan
Jefferies Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Maintains Target Price $52 - Moomoo
Morgan Stanley Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Raises Target Price to $57 - Moomoo
Avalyn Pharma (NASDAQ:AVLN) Hits New 52-Week High Following Better-Than-Expected Earnings - MarketBeat
AVLN SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Avalyn Pharma Q2 Results: EPS misses estimate by 22.64% - scanx.trade
Avalyn Pharma (NASDAQ:AVLN) Trading Up 8.2% Following Better-Than-Expected Earnings - MarketBeat
Form 8K Avalyn Pharma Inc. For: 12 August By Investing.com - Investing.com Nigeria
Avalyn Pharma Inc. Q2 2026: Net loss $(28.9M), EPS $(0.98) — 10-Q Summary - TradingView
Avalyn Pharma's Q2 Net Loss Widens - Yahoo Finance
Avalyn: Q2 Earnings Snapshot - AOL.com
AVLN: Completed Phase 2b trial enrollment and secured $413.5M cash runway into 2029 - TradingView
AVLN: Net loss widened on higher R&D spend; IPO proceeds extend cash runway into 2029 - TradingView
Avalyn Pharma reports Q2 2026 net loss $28.9M; cash $413.5M, runway into 2029 - TradingView
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights - marketscreener.com
Avalyn Pharma Inc. (NASDAQ:AVLN) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Finanzdaten der Avalyn Pharma Inc-Aktie (AVLN)
Es liegen keine Finanzdaten für Avalyn Pharma Inc (AVLN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):